Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

19.04 -0.36 (-1.86%)
Streaming Delayed Price Updated: 9:43 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
To sell or not to sell? ↗
Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho 
Via Talk Markets
News headline image
Wednesday Global Investing Report ↗
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international... 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... 
Via Benzinga
News headline image
Thursday Markets Overview ↗
Today we are seeing an across-the-board rise in stock prices on hopes for lower inflation and Omicron jabbing. 
Via Talk Markets
News headline image
Expert Ratings For Theravance Biopharma ↗
Within the last quarter, Theravance Biopharma (NASDAQ:TBPH) has observed t... 
Via Benzinga
News headline image
Happy December ↗
Inflation levels this year will almost certainly lower growth in 2022 because of inflation this year in everything from house prices....to stock prices. 
Via Talk Markets
News headline image
Theravance Biopharma Pulls Plug On Izencitinib Crohn's Disease Trial ↗
Theravance Biopharma Inc (NASDAQ: TBPH) has voluntarily discontinued its Phase 2 study of izencitinib (gut-selective oral pan-JAK inhibitor) in Crohn’s... 
Via Benzinga
News headline image
Veteran's Day ↗
Stock markets took a tumble today across the board, but not as far down as at the opening. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021 ↗
Upgrades For IGM Biosciences Inc (NASDAQ: 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Jobs Report ↗
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million... 
Via Benzinga
News headline image
Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript ↗
TBPH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
More Chinese Trouble ↗
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
News headline image
A Bit Of A Recovery ↗
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week. 
Via Talk Markets
News headline image
Earnings Scheduled For November 3, 2021 ↗
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
News headline image
China's Rescue Of Evergrand ↗
The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging. 
Via Talk Markets
News headline image
Analyst Ratings For Theravance Biopharma ↗
Analysts have provided the following ratings for Theravance Biopharma (NASDAQ:T... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Thursday ↗
Barclays boosted Adobe Inc. (NASDAQ:ADBE) price t... 
Via Benzinga
News headline image
Why Theravance Biopharma Stock Dived 16% Today ↗
The biotech is not enjoying a winning streak with its pipeline drugs. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares... 
Via Benzinga
News headline image
53 Biggest Movers From Yesterday ↗
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
Via Benzinga
Topics Initial Public Offering
News headline image
Why Are Theravance Bio Shares Plummeting Premarket Today? ↗
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows. Significant Points: Campbell Soup (NYSE:CPB) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.